SOPHARMA AD (the “Company”) hereby informs that from 24 October 2013 up to and including 30 October 2013 the Company bought 18 733 own shares representing 0.014% of the share capital of the Company, to the total value of 61 361.46  BGN on the Bulgarian Stock Exchange. The average price per share was 3.28 BGN.

The shares have been bought on the basis of decision No. 7 of the Annual General Meeting of Shareholders from 23 June 2010.

The total number of treasury shares after these transactions is 5 350 803, representing 4.05% of the share capital of the Company.

On the Day of Enlighteners – 1st November 2013, our little cozy library will be opened at Sopharma AD, 16 Iliensko Shose Str., next to the methodology room! All colleagues can come and see the books and magazines available for reading during the lunch break or for taking home for a short period of time.

The Board of Directors of SOPHARMA AD (the “Company”) hereby informs that from 19 July 2012 up to and including 25 July 2012 the Company bought 3435 own shares representing 0.0026% of the share capital of the Company, to the total value of BGN 7607.87 on the Bulgarian Stock Exchange. The average price per share was BGN 2.215.

The shares have been bought on the basis of the general meeting resolution of 23.06.2010.

The intention of the Company is to use the repurchased shares in the future for the purpose of providing them to shareholders of companies targeted in mergers.

We would like to notify that for the month of June, 2012 Sopharma AD realized increase of sales revenues of 5% compared with the same month of the previous year, including increase of export sales of 10 % and 8% decrease of domestic sales.

During the first six months of this year Sopharma AD realized increase of sales revenues of 2%, including 12% decrease of domestic sales and 7% increase of export sales compared with the same period of 2011.

Sopharma AD (the “Company”) notifies that for July 2014 the Company recorded an increase of sales revenues of 7% compared to the same period of 2013, including 2% increase of domestic sales and 16% increase of export sales.

During the past seven months Sopharma AD recorded a decrease of sales revenues of 4%, including 2% increase of domestic sales and 7% decrease of export sales compared to 2013.

SOPHARMA AD (the “Company”) hereby informs that from 31 July 2014 up to and including 6 August 2014 the Company bought 14 606 own shares representing 0.011% of the share capital of the Company, to the total value of 61 172.17BGN on the Bulgarian Stock Exchange, the average price per share was 4.19 BGN.

The trading of treasury shares is pursuant to decision by the Annual General Meeting of Shareholders from 23 June 2010.

The total number of treasury shares after these transactions is 5 061 634, representing 3.83% of the share capital of the Company.

SOPHARMA AD (the “Company”) hereby informs that from 07 August 2014 up to and including 13 August 2014 the Company bought 3 468 own shares representing 0.0026% of the share capital of the Company, to the total value of 14 632.56 BGN on the Bulgarian Stock Exchange, the average price per share was 4.22 BGN.

The trading of treasury shares is pursuant to decision by the Annual General Meeting of Shareholders from 23 June 2010.

The total number of treasury shares after these transactions is 5 065 102, representing 3.84 % of the share capital of the Company.

SOPHARMA AD (the “Company”) hereby informs that from 14 August 2014 up to and including 20 August 2014 the Company bought 773 own shares representing 0.0006% of the share capital of the Company, to the total value of 3 261.40 BGN on the Bulgarian Stock Exchange, the average price per share was 4.22 BGN.

The trading of treasury shares is pursuant to decision by the Annual General Meeting of Shareholders from 23 June 2010.

The total number of treasury shares after these transactions is 5 065 875, representing 3.84 % of the share capital of the Company.

SOPHARMA AD (the “Company”) hereby informs that from 21 August 2014 up to and including 27 August 2014 the Company bought 1 280 own shares representing 0.00097% of the share capital of the Company, to the total value of 5 400.92 BGN on the Bulgarian Stock Exchange, the average price per share was 4.219 BGN.

The trading of treasury shares is pursuant to decision by the Annual General Meeting of Shareholders from 23 June 2010.

The total number of treasury shares after these transactions is 5 067 155, representing 3.84% of the share capital of the Company.

SOPHARMA  AD (the “Company”) notifies that for October 2013 the Company recorded a decrease of sales revenues of 3% compared to the same period of 2012, including 5% decrease of domestic sales and 3% decrease of export sales.

During the past ten months Sopharma AD recorded a decrease of sales revenues of 1%, including 5% increase of domestic sales and 3% decrease of export sales compared to the same period of 2012.